Drug Trial Radar · NCT00391807
Study of Safety and Efficacy of an Oral Contraceptive
Last checked: Nov 20, 2026Latest source record: Apr 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,683
Actual
Start
Nov 2006
Primary completion
Aug 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- Warner ChilcottIndustry
- Sponsor type
- Industry
- First posted
- Oct 24, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a non-comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding; and to assess the safety and tolerability of the product.
Conditions
- Contraception
Interventions
Norethindrone acetate/ethinyl estradiolDrug
one tablet per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy Rate (Expressed as Pearl Index) in Women Aged 18 to 35, MITT Population,Time frame: 13 cycles, 28 days each (1 year)
- Pregnancy Rate (Expressed as Pearl Index) in Women Aged 18-45, MITT PopulationTime frame: 13 Cycles, 28 days each (1 year)
Locations
66 sites in 1 country. Site status is shown where the registry gives one.
Warner Chilcott Investigational Site
Phoenix, Arizona
Warner Chilcott Investigational Site
Phoenix, Arizona
Warner Chilcott Investigational Site
Phoenix, Arizona
Warner Chilcott Investigational Site
Phoenix, Arizona
Warner Chilcott Investigational Site
Tempe, Arizona
Warner Chilcott Investigational Site
Tempe, Arizona
Warner Chilcott Investigational Site
Tucson, Arizona
Warner Chilcott Investigational Site
Carmichael, California
Warner Chilcott Investigational Site
San Diego, California
Warner Chilcott Investigational Site
San Diego, California
Warner Chilcott Investigational Site
Denver, Colorado
Warner Chilcott Investigational Site
Boynton Beach, Florida
Warner Chilcott Investigational Site
Clearwater, Florida
Warner Chilcott Investigational Site
Jacksonville, Florida
Warner Chilcott Investigational Site
Leesburg, Florida
Warner Chilcott Investigational Site
Longwood, Florida
Warner Chilcott Investigational Site
Miami, Florida
Warner Chilcott Investigational Site
Miami, Florida
Warner Chilcott Investigational Site
New Port Richey, Florida
Warner Chilcott Investigational Site
Pembroke Pines, Florida
Warner Chilcott Investigational Site
Plantation, Florida
Warner Chilcott Investigational Site
St. Petersburg, Florida
Warner Chilcott Investigational Site
West Palm Beach, Florida
Warner Chilcott Investigational Site
West Palm Beach, Florida
Warner Chilcott Investigational Site
Roswell, Georgia
Warner Chilcott Investigational Site
Sandy Springs, Georgia
Warner Chilcott Investigational Site
Champaign, Illinois
Warner Chilcott Investigational Site
Peoria, Illinois
Warner Chilcott Investigational Site
Indianapolis, Indiana
Warner Chilcott Investigational Site
Wichita, Kansas
Warner Chilcott Investigational Site
Lexington, Kentucky
Warner Chilcott Investigational Site
Louisville, Kentucky
Warner Chilcott Investigational Site
Louisville, Kentucky
Warner Chilcott Investigational Site
Berlin, New Jersey
Warner Chilcott Investigational Site
Lawrenceville, New Jersey
Warner Chilcott Investigational Site
Moorestown, New Jersey
Warner Chilcott Investigational Site
Albuquerque, New Mexico
Warner Chilcott Investigational Site
Cary, North Carolina
Warner Chilcott Investigational Site
New Bern, North Carolina
Warner Chilcott Investigational Site
Raleigh, North Carolina
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.